IldikoCsikiMD
Radiology • Philadelphia, PAUltrasound
Assistant Professor, Radiation Oncology, Perelman School of Medicine
Dr. Csiki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd.
Rad Onc/Trc 2 West
Philadelphia, PA 19104Phone+1 215-662-2428
Education & Training
Vanderbilt University Medical CenterResidency, Radiation Oncology, 2008 - 2012- Vanderbilt University Medical CenterInternship, Internal Medicine, 2007 - 2008
Vanderbilt University School of MedicineClass of 2007
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Addition of SNS-301 to Checkpoint Inhibitor Treatment in Metastatic/Recurrent SCCHN Start of enrollment: 2019 Nov 11
- SNS-301 Monotherapy in High Risk MDS and CMML Start of enrollment: 2020 Apr 01
Publications & Presentations
PubMed
- 16 citationsPersonalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial.Mark Yarchoan, Edward J Gane, Thomas U Marron, Renzo Perales-Linares, Jian Yan
Nature Medicine. 2024-04-01 - 90 citationsImmunotherapy Targeting HPV16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer.Charu Aggarwal, Roger B. Cohen, Matthew P. Morrow, Kimberly A. Kraynyak, Albert Sylvester
Clinical Cancer Research. 2019-01-01 - 18 citationsAnti-Vascular Endothelial Growth Factor Treatment in Combination with Chemotherapy Delays Hematopoietic Recovery Due to Decreased Proliferation of Bone Marrow Hematopo...Sergey V. Novitskiy, Ildiko Csiki, Yuhui Huang, David H. Johnson, Eva Harth
Journal of Thoracic Oncology. 2010-09-01
Press Mentions
Coherus BioSciences Names Physician-Scientist Ildiko Csiki, M.D., Ph.D., Chair of Its Scientific Advisory BoardJuly 21st, 2021
Development of a Multi-Antigenic SARS-CoV-2 Vaccine Candidate Using a Synthetic Poxvirus PlatformNovember 30th, 2020- Chutes & Ladders—Novavax Appoints AstraZeneca Vet Dubovsky to CMO RoleJune 19th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
